Brainsway Deep TMS Therapy - for Brain Disorder Treatment

CE Mark Approval for the Treatment of Chronic Neuropathic Pain with Brainsway's Deep TMS

Monday, July 2, 2012

The Company is pleased to report the that it has received the European Union’s CE Mark, which permits the marketing and sale of the Company’s deep TMS device in Europe, for the treatment of chronic neuropathic pain.

For more on the significance of the CE Mark marketing approval, please refer to the Brainsway ® periodic report for 2011.

© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use